Skip to main content
. 2022 Jul 28;8(9):1317–1322. doi: 10.1001/jamaoncol.2022.2181

Figure 3. Progression-Free Survival.

Figure 3.

A, Patients with and without homologous recombination repair (HRR) alterations. B, Patients with and without switch/sucrose nonfermentable complex (SWI/SNF) alterations. C, Patients with a platinum-free interval (PFI) of 6 months or longer and PFI of less than 6 months. D, Patients with HRR-altered tumors or PFI of 6 months or longer vs those with no HRR alterations and a PFI of less than 6 months.